Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin

Diabetologia

Volumn 40, Issue 11, 1997, Pages 1263-1268

  Fraser, R B ^a,b   Rowden, G ^b   Colp, P ^b   Wright, J R ^a,b  

^a IWK HEALTH CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

essential fatty acid deficiency; insulitis; streptozotocin; T lymphocytemacrophage

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; STREPTOZOCIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESSENTIAL FATTY ACID DEFICIENCY; IMMUNOPHENOTYPING; INSULITIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS, ESSENTIAL; IMMUNOPHENOTYPING; ISLETS OF LANGERHANS; LYMPHOCYTES; MACROPHAGES; MALE; MICE; STREPTOZOCIN; TIME FACTORS;

EID: 0030827520     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s001250050819     Document Type: Article

References (31)

1. 1. GL Wilson EH Leiter 1990 Streptozotocin interactions with pancreatic B cells and the induction of insulin-dependent diabetes Curr Top Microbiol Immunol 156 27 54 2143132 1:STN:280:DyaK3czjs1eqtQ%3D%3D Wilson GL, Leiter EH (1990) Streptozotocin interactions with pancreatic B cells and the induction of insulin-dependent diabetes. Curr Top Microbiol Immunol 156: 27–54
2. 2. WJ Schnedl S Ferber JH Johnson CB Newgard 1994 STZ transport and cytotoxicity — specific enhancement in GLUT2-expressing cells Diabetes 43 1326 1333 7926307 10.2337/diabetes.43.11.1326 1:CAS:528:DyaK2cXmslWrtro%3D Schnedl WJ, Ferber S, Johnson JH, Newgard CB (1994) STZ transport and cytotoxicity — specific enhancement in GLUT2-expressing cells. Diabetes 43: 1326–1333
3. 3. H Okamoto 1985 Molecular basis of experimental diabetes: degeneration, oncogenesis, and regeneration of pancreatic B-cells of islets of Langerhans Bioessays 2 15 21 10.1002/bies.950020106 1:CAS:528:DyaL2MXksFajs78%3D Okamoto H (1985) Molecular basis of experimental diabetes: degeneration, oncogenesis, and regeneration of pancreatic B-cells of islets of Langerhans. Bioessays 2: 15–21
4. 4. AA Like AA Rossini 1976 Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus Science 193 415 417 180605 10.1126/science.180605 1:CAS:528:DyaE28XkvFWlsrs%3D Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193: 415–417
5. 5. H Kolb 1987 Mouse models of insulin dependent diabetes mellitus: low-dose streptozotocin-induced diabetes and nonobese diabetic (NOD) mice Diabetes Metab Rev 3 751 778 2956075 1:STN:280:DyaL2s3nsFegtQ%3D%3D 10.1002/dmr.5610030308 Kolb H (1987) Mouse models of insulin dependent diabetes mellitus: low-dose streptozotocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab Rev 3: 751–778
6. 6. H Kolb KD Kröcke 1993 Lessons from the low-dose streptozotocin model in mice Diabetes Rev 1 116 126 Kolb H, Kröcke KD (1993) Lessons from the low-dose streptozotocin model in mice. Diabetes Rev 1: 116–126
7. 7. AA Rossini MC Appel RM Williams AA Like 1977 Genetic influence of the streptozotocin-induced insulitis and hyperglycemia Diabetes 26 916 920 143386 10.2337/diabetes.26.10.916 1:CAS:528:DyaE2sXlvVajsb8%3D Rossini AA, Appel MC, Williams RM, Like AA (1977) Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes 26: 916–920
8. 8. U Kiesel B Greulich CM-S Moume H Kolb 1981 Induction of experimental autoimmune diabetes by low-dose streptozotocin treatment in genetically resistant mice Immunol Letters 3 227 230 10.1016/0165-2478(81)90079-1 1:STN:280:DyaL38%2FnsVGluw%3D%3D Kiesel U, Greulich B, Moume CM-S, Kolb H (1981) Induction of experimental autoimmune diabetes by low-dose streptozotocin treatment in genetically resistant mice. Immunol Letters 3: 227–230
9. 9. L Weide P Lacy H Smith K Tung 1991 Adoptive transfer of low-dose streptozotocin autoimmune diabetes in a non-susceptible strain Diabetes 40 1 56A 56A Weide L, Lacy P, Smith H, Tung K (1991) Adoptive transfer of low-dose streptozotocin autoimmune diabetes in a non-susceptible strain. Diabetes 40 [Suppl 1]: 56A (Abstract)
10. 10. JR Wright RB Fraser S Kapoor HW Cook 1995 Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in naive and cyclosporintreated low-responder murine strains Acta Diabetol 32 125 130 7579534 10.1007/BF00569571 1:CAS:528:DyaK2MXnsFCru7c%3D Wright JR Jr, Fraser RB, Kapoor S, Cook HW (1995) Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in naive and cyclosporintreated low-responder murine strains. Acta Diabetol 32: 125–130
11. 11. JR Jr Wright B Haliburton H Russell M Henry R Fraser HW Cook 1991 The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocintreated mice persists if essential fatty acid repletion occurs outside a brief window of susceptibility Diabetologia 34 709 714 1835705 10.1007/BF00401515 1:CAS:528:DyaK38XktVanuw%3D%3D Wright JR Jr, Haliburton B, Russell H, Henry M, Fraser R, Cook HW (1991) The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocintreated mice persists if essential fatty acid repletion occurs outside a brief window of susceptibility. Diabetologia 34: 709–714
12. 12. JR Wright JB Lefkowith G Schreiner PE Lacy 1988 Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice Proc Natl Acad Sci USA 85 6137 6141 3045812 10.1073/pnas.85.16.6137 1:CAS:528:DyaL1cXlt1OrsL0%3D Wright JR Jr, Lefkowith JB, Schreiner G, Lacy PE (1988) Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice. Proc Natl Acad Sci USA 85: 6137–6141
13. 13. JG Lawen JR Wright W Yu HR Epstein 1991 Donor essential fatty acid deficiency does not prolong heterotopic cardiac allograft survival in rats Transplantation 52 178 180 1858147 1:STN:280:DyaK3MzhtlKmuw%3D%3D 10.1097/00007890-199107000-00043 Lawen JG, Wright JR Jr, Yu W, Epstein HR (1991) Donor essential fatty acid deficiency does not prolong heterotopic cardiac allograft survival in rats. Transplantation 52: 178–180
14. 14. JG Lawen W Yu HW Cook JR Wright 1993 The failure of donor essential fatty acid deficiency to prevent renal allograft rejection in rats Transplantation 56 1269 1270 8249137 1:STN:280:DyaK2c%2FmvFOmtg%3D%3D Lawen JG, Yu W, Cook HW, Wright JR Jr (1993) The failure of donor essential fatty acid deficiency to prevent renal allograft rejection in rats. Transplantation 56: 1269–1270
15. 15. G Rowden 1984 Antigenic markers of epidermal Langerhans cells D Skerrous CJ Skerrous Methods in skin research John Wiley and Sons New York 91 144 Rowden G (1984) Antigenic markers of epidermal Langerhans cells. In: Skerrous D, Skerrous CJ (eds) Methods in skin research. John Wiley and Sons, New York, pp 91–144
16. 16. KC Herald AG Montag FW Fitch 1987 Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozotocin Diabetes 36 796 801 10.2337/diabetes.36.7.796 Herald KC, Montag AG, Fitch FW (1987) Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozotocin. Diabetes 36: 796–801
17. 17. G Kantwerk S Cobbold H Waldmann H Kolb 1987 L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice Clin Exp Immunol 70 585 592 2963718 1:CAS:528:DyaL1cXntlGmuw%3D%3D Kantwerk G, Cobbold S, Waldmann H, Kolb H (1987) L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice. Clin Exp Immunol 70: 585–592
18. 18. V Kolb-Bachofen S Epstein U Kiesel H Kolb 1988 Low-dose streptozotocin-induced diabetes in mice: electron microscopy reveals single cell insulitis before diabetes onset Diabetes 37 21 27 3275555 10.2337/diabetes.37.1.21 1:STN:280:DyaL1c%2Fotl2quw%3D%3D Kolb-Bachofen V, Epstein S, Kiesel U, Kolb H (1988) Low-dose streptozotocin-induced diabetes in mice: electron microscopy reveals single cell insulitis before diabetes onset. Diabetes 37: 21–27
19. 19. M Oschilewski E Schwab U Kiesel 1986 Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin-induced diabetes in mice Immunol Lett 12 289 294 3015785 10.1016/0165-2478(86)90032-5 1:CAS:528:DyaL28XksF2hurY%3D Oschilewski M, Schwab E, Kiesel U et al. (1986) Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin-induced diabetes in mice. Immunol Lett 12: 289–294
20. 20. EH Leiter 1985 Differential susceptibility of BALB/c sublines to diabetes induction by multi-dose streptozotocin treatment Curr Top Microbiol Immunol 122 78 85 2931251 1:STN:280:DyaL28%2FgtlGqtA%3D%3D Leiter EH (1985) Differential susceptibility of BALB/c sublines to diabetes induction by multi-dose streptozotocin treatment. Curr Top Microbiol Immunol 122: 78–85
21. 21. A Andersson 1979 Islet implantation normalizes hyperglycaemia caused by streptozotocin-induced insulitis: experiments in mice Lancet 1 581 584 85167 10.1016/S0140-6736(79)91008-0 1:STN:280:DyaE1M7jtl2jtg%3D%3D Andersson A (1979) Islet implantation normalizes hyperglycaemia caused by streptozotocin-induced insulitis: experiments in mice. Lancet 1: 581–584
22. 22. L Weide P Lacy 1991 Low-dose streptozotocin-induced autoimmune diabetes in an islet transplantation mode Diabetes 40 1157 1162 1834505 10.2337/diabetes.40.9.1157 1:CAS:528:DyaK3MXlvVWht7c%3D Weide L, Lacy P (1991) Low-dose streptozotocin-induced autoimmune diabetes in an islet transplantation mode. Diabetes 40: 1157–1162
23. 23. JB Lefkowith 1988 Essential fatty acid deficiency inhibits the in vivo generation of leukotriene B4 and suppresses levels of resident and elicited leukocytes in acute inflammation J Immunol 140 228 233 2826589 1:CAS:528:DyaL1cXnsVaitA%3D%3D Lefkowith JB (1988) Essential fatty acid deficiency inhibits the in vivo generation of leukotriene B4 and suppresses levels of resident and elicited leukocytes in acute inflammation. J Immunol 140: 228–233
24. 24. GF Schreiner B Rovin JB Lefkowith 1989 The anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. The modulation of macrophage migration and eicosanoid metabolism J Immunol 143 3192 3199 2809195 1:CAS:528:DyaK3cXitVartA%3D%3D Schreiner GF, Rovin B, Lefkowith JB (1989) The anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. The modulation of macrophage migration and eicosanoid metabolism. J Immunol 143: 3192–3199
25. 25. WJ Malaisse F Malaisse-Lagae A Sener DG Pipeleers 1982 Determinants of the selective toxicity of alloxan to the beta cell Proc Natl Acad Sci USA 79 927 930 7038690 10.1073/pnas.79.3.927 1:CAS:528:DyaL38XhtlOgsLs%3D Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG (1982) Determinants of the selective toxicity of alloxan to the beta cell. Proc Natl Acad Sci USA 79: 927–930
26. 26. K Grankvist SL Marklund I-B Taljedal 1981 CuZn-su-peroxide dismutase MN-superoxide dismutase, catalase, and glutathione peroxidase in pancreatic islets and other tissues of the mouse Biochem J 199 393 398 7041886 1:CAS:528:DyaL38XhslKqtg%3D%3D Grankvist K, Marklund SL, Taljedal I-B (1981) CuZn-su-peroxide dismutase MN-superoxide dismutase, catalase, and glutathione peroxidase in pancreatic islets and other tissues of the mouse. Biochem J 199: 393–398
27. 27. T Mandrup-Poulsen S Helqvist LD Wogensen 1990 Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells Curr Top Microbiol Immunol 164 169 193 2073784 1:STN:280:DyaK3M7mtValtA%3D%3D Mandrup-Poulsen T, Helqvist S, Wogensen LD et al. (1990) Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol 164: 169–193
28. 28. J Mendola JR Wright PE Lacy 1989 Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozotocin-induced insulitis Diabetes 38 379 385 2521836 10.2337/diabetes.38.3.379 1:STN:280:DyaL1M7jslOqtQ%3D%3D Mendola J, Wright JR Jr, Lacy PE (1989) Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozotocin-induced insulitis. Diabetes 38: 379–385
29. 29. G Schreiner A Rossini J Mordes 1988 Essential fatty acid deficiency inhibits the development of diabetes in rats Diabetes 37 1 80A 80A Schreiner G, Rossini A, Mordes J et al. (1988) Essential fatty acid deficiency inhibits the development of diabetes in rats. Diabetes 37 [Suppl 1]: 80A (Abstract)
30. 30. D Lenrow J Luketich A Naji C Barker 1989 Immune modulation of the BB rats by essential fatty acid deficient (EFAD) diet Diabetes 38 2 74A 74A Lenrow D, Luketich J, Naji A, Barker C (1989) Immune modulation of the BB rats by essential fatty acid deficient (EFAD) diet. Diabetes 38 [Suppl 2]: 74A (Abstract)
31. 31. J Lefkowith G Schreiner J Cormier 1990 Prevention of diabetes in the BB rat by essential fatty acid deficiency: relationship between physiological and biochemical changes J Exp Med 171 729 743 2307932 10.1084/jem.171.3.729 1:CAS:528:DyaK3cXhsFOisLs%3D Lefkowith J, Schreiner G, Cormier J et al. (1990) Prevention of diabetes in the BB rat by essential fatty acid deficiency: relationship between physiological and biochemical changes. J Exp Med 171: 729–743